Literature DB >> 10864583

Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli.

Corina Lorz1, Alberto Ortiz1, Pilar Justo1, Silvia González-Cuadrado1, Natalia Duque1, Carmen Gómez-Guerrero1, Jesús Egido1.   

Abstract

Fas ligand (FasL) is a cell membrane cytokine that can promote apoptosis through activation of Fas receptors. Fas receptor activation induces glomerular cell apoptosis in vivo and participates in tubular cell death during acute renal failure. However, there is little information on the expression of FasL in the kidney. This study reports that FasL mRNA and protein are present in normal mouse and rat kidney. In situ hybridization and immunohistochemistry showed that proximal tubular epithelium is the main site of FasL expression in the normal kidney. In addition, increased total kidney FasL mRNA and de novo FasL protein expression by glomerular cells were observed in two different models of glomerular injury : rat immune-complex proliferative glumerulonephritis and murine lupus nephritis. Both full-length and soluble FasL were increased in the kidneys of the mice with nephritis. Cultured murine proximal tubular epithelial MCT cells and primary cultures of murine tubular epithelial cells expressed FasL mRNA and protein. Tubular epithelium-derived FasL induced apoptosis in Fassensitive lymphoid cell lines but not in Fas-resistant lymphoid cell lines. By contrast, MCT cells grown in the presence of the survival factors of serum were resistant to FasL, and only became partially sensitive to apoptosis induced by high concentrations (100 ng/ml) of FasL upon serum deprivation. However, MCT cells stimulated with inflammatory mediators (tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide) increased cell surface Fas expression and were sensitized to apoptosis induced by FasL (FasL 55 +/- 5% versus control 8.3 +/- 4.1% apoptotic cells at 24 h, P < 0.05). Cytokine-primed primary cultures of tubular epithelial cells also acquired sensitivity to FasL-induced apoptosis. These results suggest that FasL expression by intrinsic renal cells may play a role in cell homeostasis in the normal kidney and during renal injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864583     DOI: 10.1681/ASN.V1171266

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

Review 1.  Cellular and Molecular Mechanisms of AKI.

Authors:  Anupam Agarwal; Zheng Dong; Raymond Harris; Patrick Murray; Samir M Parikh; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

2.  p53 target Siva regulates apoptosis in ischemic kidneys.

Authors:  Kurinji Singaravelu; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-09

3.  The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.

Authors:  Song Rong; Joon-Keun Park; Torsten Kirsch; Hideo Yagita; Hisaya Akiba; Olaf Boenisch; Hermann Haller; Nader Najafian; Antje Habicht
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

4.  Loss of α(E)-catenin promotes Fas mediated apoptosis in tubular epithelial cells.

Authors:  Xinhui Wang; Alan R Parrish
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

5.  BASP1 promotes apoptosis in diabetic nephropathy.

Authors:  Maria Dolores Sanchez-Niño; Ana Belen Sanz; Corina Lorz; Andrea Gnirke; Maria Pia Rastaldi; Viji Nair; Jesus Egido; Marta Ruiz-Ortega; Matthias Kretzler; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

6.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

7.  The death ligand TRAIL in diabetic nephropathy.

Authors:  Corina Lorz; Alberto Benito-Martín; Anissa Boucherot; Alvaro C Ucero; Maria Pia Rastaldi; Anna Henger; Silvia Armelloni; Beatriz Santamaría; Celine C Berthier; Matthias Kretzler; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

8.  TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21.

Authors:  Ana B Sanz; Maria D Sanchez-Niño; Maria C Izquierdo; Aniela Jakubowski; Pilar Justo; Luis M Blanco-Colio; Marta Ruiz-Ortega; Rafael Selgas; Jesús Egido; Alberto Ortiz
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

Review 9.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

10.  The cytokine TWEAK modulates renal tubulointerstitial inflammation.

Authors:  Ana Belen Sanz; Pilar Justo; Maria Dolores Sanchez-Niño; Luis Miguel Blanco-Colio; Jeffrey A Winkles; Matthias Kreztler; Aniela Jakubowski; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.